Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Btaiche, I.
Right arrow Articles by Khalidi, N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Btaiche, I.
Right arrow Articles by Khalidi, N
American Journal of Health-System Pharmacy, Vol 61, Issue 18, 1938-1949
Copyright © 2004 by American Society of Health-System Pharmacists


Articles

Metabolic complications of parenteral nutrition in adults, part 1

IF Btaiche and N Khalidi


PURPOSE: Common metabolic complications associated with parenteral nutrition (PN) are reviewed, and the consequences of overfeeding and variables for patient monitoring are discussed. SUMMARY: Although PN is a lifesaving therapy in patients with gastrointestinal failure, its use may be associated with metabolic, infectious, and technical complications. The metabolic complications associated with PN in adult patients include hyperglycemia, hypoglycemia, hyperlipidemia, hypercapnia, refeeding syndrome, acid-base disturbances, liver complications, manganese toxicity, and metabolic bone disease. These complications may occur in the acute care or chronic care patient. The frequency and severity of these complications depend on patient- and PN-specific factors. Proper assessment of the patient's nutritional status; tailoring the macronutrient, micronutrient, fluid, and electrolyte requirements on the basis of the patient's underlying diseases, clinical status, and drug therapy; and monitoring the patient's tolerance of and response to nutritional support are essential in avoiding these complications. Early recognition of the signs and symptoms of complications and knowledge of the available pharmacologic and nonpharmacologic therapies are essential to proper management. PN should be used for the shortest period possible, and oral or enteral feeding should be initiated as soon as is clinically feasible. The gastrointestinal route remains the most physiologically appropriate and cost-effective way of providing nutritional support. CONCLUSION: PN can lead to serious complications, many of which are associated with overfeeding. Close management is necessary to recognize and manage these complications.
 



This article has been cited by other articles:


Home page
ChestHome page
N. Gill, J. V. Nally Jr, and R. A. Fatica
Renal Failure Secondary to Acute Tubular Necrosis: Epidemiology, Diagnosis, and Management
Chest, October 1, 2005; 128(4): 2847 - 2863.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Society of Health-System Pharmacists.